Product Description
| Benzylpenicillin Sodium for Inj. |
0.8mega/1mega/1.6mega/2mega/5mega/10mega |
1/10/50vial/box,600/1000vial/carton |
BP |
| Benzylpenicillin Potassium for Inj. |
1mega |
1/10/50vial/box,600/1000vial/carton |
BP |
|
AI Product Description
*The following content is generated by AI and is for reference only.
Benzylpenicillin Sodium for Injection is a potent, narrow-spectrum antibiotic belonging to the penicillin class. Primarily used for treating serious bacterial infections, it functions by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. This medication is indicated for conditions such as pneumococcal pneumonia, meningitis, syphilis, anthrax, actinomycosis, and severe streptococcal or staphylococcal infections, provided the causative organisms are sensitive. Due to its instability in acidic environments, it must be administered parenterally, typically via intravenous infusion or deep intramuscular injection, ensuring rapid therapeutic blood levels.
The product is supplied as a sterile powder requiring reconstitution with specific diluents immediately before administration. Once mixed, solutions should be used promptly to prevent degradation. A critical safety consideration is the risk of severe hypersensitivity reactions, including anaphylaxis, which can be life-threatening. Patients with a history of penicillin or cephalosporin allergy must avoid this drug unless desensitization protocols are strictly followed. Healthcare providers should always perform skin testing prior to the first dose if feasible, though clinical judgment remains paramount.
Other important precautions include monitoring renal function, as the drug is primarily excreted unchanged by the kidneys; dosage adjustments are necessary for patients with renal impairment to prevent neurotoxicity. High doses may cause seizures, particularly in individuals with compromised blood-brain barriers or existing neurological disorders. Additionally, prolonged use can lead to superinfections, such as candidiasis or pseudomembranous colitis caused by Clostridioides difficile. The formulation contains sodium, so caution is advised in patients on strict sodium-restricted diets. Proper aseptic technique during preparation is essential to maintain sterility. While highly effective against susceptible Gram-positive cocci and some Gram-negative bacteria, resistance is common among Staphylococcus aureus strains producing beta-lactamase. Therefore, susceptibility testing guides appropriate therapy. Always consult current prescribing information and adhere to local antimicrobial stewardship guidelines to ensure optimal patient outcomes and minimize resistance development.